Gainers
• Miragen Therapeutics, Inc. MGEN stock rose 63.9% to $2.77 during Thursday's pre-market session. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00.
• Novus Therapeutics, Inc. NVUS stock rose 33.3% to $0.80. The most recent rating by H.C. Wainwright, on November 27, is at Buy, with a price target of $2.00.
• Myos Rens Technology, Inc. MYOS shares moved upwards by 30.3% to $1.85.
• Lianluo Smart, Inc. LLIT stock surged 21.9% to $2.34.
• Inovio Pharmaceuticals, Inc. INO shares increased by 15.8% to $4.76. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
• Vaxart, Inc. VXRT shares moved upwards by 8.2% to $0.78.
• Cleveland BioLabs, Inc. CBLI stock moved upwards by 8.1% to $2.41.
• China SXT Pharmaceuticals, Inc. SXTC shares moved upwards by 6.9% to $0.99.
• Kadmon Holdings, Inc. KDMN stock surged 6.9% to $4.80. The most recent rating by Nomura Instinet, on January 10, is at Buy, with a price target of $10.00.
• Soligenix, Inc. SNGX stock moved upwards by 6.4% to $2.81.
• Establishment Labs Hldgs, Inc. ESTA shares moved upwards by 3.6% to $27.52.
• Novavax, Inc. NVAX shares moved upwards by 3.2% to $7.06.
Losers
• Conatus Pharmaceuticals, Inc. CNAT stock plummeted 14.0% to $0.40 during Thursday's pre-market session.
• Ekso Bionics Holdings, Inc. EKSO stock declined 11.9% to $0.37.
• DBV Technologies, Inc. DBVT shares plummeted 8.6% to $10.36. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.
• Catabasis Pharmaceuticals, Inc. CATB shares declined 6.3% to $5.31.
• Genprex, Inc. GNPX shares declined 4.4% to $1.51.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.